NASDAQ · Financial Statements
AnPac Bio-Medical Science Co., Ltd. (ANPC) Financial Statements
$4.30
NASDAQ: ANPC
Market Cap $26.97M
Overview Financials Dividend AnPac Bio-Medical Science Co., Ltd. most recently reported annual revenue of $12.0M, net profit of $-104.0M, revenue has compounded at 14.9% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2018 2019 2020 2021 2022 Revenue $10.0M $11.0M $21.0M $18.0M $12.0M Operating Profit $-44.0M $-89.0M $-93.0M $-106.0M $-84.0M Net Profit $-42.0M $-102.0M $-81.0M $-120.0M $-104.0M EPS $-3.76 $-205.96 $-143.99 $-176.53 $-54.18 Op Margin -425.4% -821.4% -454.1% -589.6% -698.6%
Balance Sheet (USD)
Metric 2018 2019 2020 2021 2022 Total Assets $53.0M $53.0M $50.0M $67.0M $40.0M Total Liabilities $75.0M $69.0M $47.0M $66.0M $50.0M Cash $13.0M $6.0M $3.0M $9.0M $2.0M Borrowings $26.0M $39.0M $8.0M $34.0M $12.0M
Cash Flow (USD)
Metric 2018 2019 2020 2021 2022 Operating Cash Flow $-31.0M $-49.0M $-59.0M $-72.0M $-55.0M Investing Cash Flow $-6.0M $-7.0M $-5.0M $-8.0M $-3.0M Financing Cash Flow $36.0M $46.0M $35.0M $83.0M $38.0M Net Cash Flow $1.0M $-7.0M $-3.0M $6.0M $-7.0M Free Cash Flow $-34.0M $-52.0M $-61.0M $-76.0M $-57.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.01 EV / EBITDA -1.94 FCF Yield -31.04% Quick Ratio 0.32 Interest Coverage -225.57 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock